KLK3 and cancer: Most comprehensively adopted protein biomarkers, i.e., prostate-specific antigen (PSA), carbohydrate antigen 125 (CA 125), and carbohydrate antigen 19-9 (CA19-9) have been used for cancer diagnosis, monitoring therapeutic responses, or disease recurrence evaluation of prostate, ovarian, and pancreatic cancers, respectively.